JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans. - Fourie AM; Cheng X; Chang L; Greving C; Li X; Knight B; Polidori D; Patrick A; Bains T; Steele R; Allen SJ; Patch RJ; et al. (Scientific reports, 2024)